ADVISORY: The Second Annual Conference on Regenerative Medicine.Business Editors & Health/Medical Writers BIOWIRE2K LARCHMONT, N.Y.--(BW HealthWire)--Nov. 27, 2001 Leading researchers, scientists, physicians, and entrepreneurs in cell biology, gene therapy, tissue engineering, and related fields will convene at the Renaissance Hotel in Washington, D.C., on December 2-4 to share the latest advances in the provocative new field of Regenerative Medicine. William A. Haseltine, Ph.D., chairman of the Symposium and editor of ebiomed: The Journal of Regenerative Medicine, will give the opening remarks on Sunday, December 1st and closing remarks on Tuesday, December 4th. Jose Cibelli, Ph.D., of Advanced Cell Technology, and the lead author of the paper on Human Therapeutic Cloning will present on Monday afternoon, December 3rd. See web site for full program: http://www.bioconferences.com/ebio A press conference has been called for Sunday, December 1st at 10:15 a.m. To obtain a press pass for the press conference, as well as the full meeting, contact Nilda Rivera. (See below for contact information.) What: The Second Annual Conference on Regenerative Medicine: Rebuilding the Human Body When: December 2-4, 2001, opening Sunday, Dec. 2, at 8:30 a.m.; concluding Tuesday, Dec. 4, at 5:00 p.m. Where: Renaissance Washington, D.C., Hotel, 999 Ninth Street N.W., Washington, D.C. Who: Dr. William A. Haseltine, Chairman & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Human Genome Sciences, Inc., conference chair, will present opening remarks, "Regenerative Medicine: A Blueprint for the Future," and the closing address, "Regenerative Medicine Next Steps: The New Society." Other distinguished participants include: Stem Cells--Session Chairs: Irving L. Weissman, Stanford U. and Andrew M. Yeager, U. of Pittsburgh. Speakers: Doros Platika, Curis Inc.; Donald Orlic, NHGRI, NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. ; Eric Lagasse, StemCells, Inc.; Denise L. Faustman, Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts. ; Annemarie B. Moseley, Osiris Therapeutics, Inc., Cyril Guey, BeFutur Biotechnologies (Switzerland), Hans Peter Zenner, The University of Tubingen (Germany) Tissue Engineering--Session Chair: Anthony Atala, Children's Hospital/Harvard Medical School. Speakers: Joseph P. Vacanti, Massachusetts General Hospital Massachusetts General Hospital Health care The major teaching hospital for Harvard Medical School, widely regarded as one of the best health care centers in the world ; Steve Badylak, Purdue University; Peter C. Johnson, TissueInformatics.Inc; Antonios G. Mikos, Rice University; John E. Mayer, Jr., Children's Hospital/Harvard Medical School Bioethics--Address by Arthur L. Caplan, U. of Pennsylvania. Cloning--Session Chair: Ian Wilmut, Roslin Institute. Speakers: Tanja Dominko and Jose Cibelli, Advanced Cell Technology; Lorenz Studer, Memorial Sloan-Kettering Cancer Center The Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets, with other locations in New . Nanobiotechnology--Session Chair: Richard W. Siegel, Rensselaer Polytechnic Institute Rensselaer Polytechnic Institute, at Troy, N.Y.; coeducational; founded and opened 1824 as Rensselaer School; chartered 1826. It was called Rensselaer Institute from 1837 to 1861. ; Shirley Ann Jackson, Rennselaer Polytechnic Institute; Cato T. Laurencin, Drexel University New Ventures--Address by Gunnar Weikert, Inventages GmbH. Longevity--Session Chair: Judith Campisi, Lawrence Berkeley National Laboratory Lawrence Berkeley National Laboratory and Lawrence Livermore National Laboratory, scientific research centers run by the Univ. of California, located in Berkeley, Calif., and Livermore, Calif., respectively. . Speakers: Simon Melov, Buck Institute for Age Research The Buck Institute for Age Research is the United States' first independent biomedical research institute devoted solely to research on aging and age-related disease. The mission of the Buck Institute is to extend the healthspan, the healthy years of life. ; John G. Tower, U. of Southern California; Arlan Richardson, U. of Texas Health Sciences Center at San Antonio. Sponsors: University of South Florida College of Medicine As of Fall 2006, there were 477 students in the M.D. program; 78 students in the M.S. and 83 students in the Ph.D. program in the School of Basic Biomedical Sciences; and 55 students in the DPT program in the School of Physical Therapy. , Regenerative Medicine and Stem Cell Biology Society, Inc., and Genetic Engineering News (www.genengnews.com) Supporters: Human Genome Sciences Human Genome Sciences NASDAQ: HGSI is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. , Inc., Toucan toucan (t  kăn`, t`kän), perching bird of the New World tropics, related to the woodpeckers. Capital Corp., BeFutur Biotechnologies, and Guava Technologies, Inc. Organizers: BioConferences International, Inc. (www.bioconferences.com, 800-5-BIOCON). Accrediting Institution: University of South Florida College of Medicine, Tampa. Details: For complete program and registration, visit the web site ttp://www.bioconferences.com/ebio Contact: Limited press attendance. To obtain press pass, please call, fax or e-mail: BioConferences International, Inc. Nilda Rivera 914-834-3100 ext. 652 nrivera@liebertpub.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion